Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

423
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
423
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

629
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
629
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

985
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
985
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

510
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
510
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

540
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
540

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Advancing Lipid Management: Saudi Heart Association Position Statement on PCSK9-targeted Therapies in the Primary and Secondary Prevention of Cardiovascular Disease.

Journal of the Saudi Heart Association·2026
Same author

National Heart Center - Saudi Health Council Acute Myocardial Infarction-Related Cardiogenic Shock Consensus Document.

Saudi medical journal·2026
Same author

The Initial Middle Eastern Experience With the Alterra Adaptive Pre-Stent: Single-Center Outcomes From Saudi Arabia.

CJC pediatric and congenital heart disease·2026
Same author

Saudi Heart Association Position Statement on Early Detection of Subclinical Atherosclerosis in Clinical Practice.

Journal of the Saudi Heart Association·2026
Same author

Saudi Heart Association Position Statement on NT-proBNP for Cardiovascular Risk Screening in Asymptomatic Adults With Type 2 Diabetes Mellitus.

Journal of the Saudi Heart Association·2026
Same author

Prevention: Bend it like Bekham.

Saudi medical journal·2025

Related Experiment Video

Updated: Mar 19, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K

Transcatheter Pulmonary Valve Replacement (TPVR): A Saudi Consensus Statement.

Khalid AlNajashi1, Ahmed Al Zahrani1, Atif Al Qabani2

  • 1Prince Sultan Cardiac Center, Riyadh, Kingdom of Saudi Arabia.

Journal of the Saudi Heart Association
|March 18, 2026
PubMed
Summary

Transcatheter pulmonary valve replacement (TPVR) is a safe and effective treatment for chronic pulmonary regurgitation in patients with congenital heart defects. This expert consensus provides guidance on patient selection, procedural planning, and device use for optimal outcomes.

Keywords:
Congenital heart diseaseImaging evaluationPulmonary regurgitationRight ventricular dysfunctionTranscatheter pulmonary valve replacementValve durability

More Related Videos

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

3.3K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.5K

Related Experiment Videos

Last Updated: Mar 19, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

3.3K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.5K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease Management

Background:

  • Chronic pulmonary regurgitation (PR) and stenosis (PS) are common sequelae after surgical repair of congenital heart defects, notably Tetralogy of Fallot (TOF).
  • Pulmonary valve dysfunction significantly impacts right ventricular (RV) remodeling and patient functional status.
  • Transcatheter pulmonary valve replacement (TPVR) has emerged as a less invasive alternative to surgical reintervention.

Purpose of the Study:

  • To establish an expert consensus on the appropriate utilization of TPVR for managing chronic PR and PS in patients with congenital heart disease.
  • To provide guidance on patient selection, procedural planning, imaging, and device considerations for TPVR.
  • To optimize clinical outcomes and standardize best practices for TPVR across diverse healthcare settings.

Main Methods:

  • A multidisciplinary expert panel convened to review existing literature, clinical guidelines, and real-world data.
  • Key areas of focus included epidemiology, anatomical/hemodynamic assessment, pre- and post-procedural imaging, device specifics, and patient selection criteria.
  • Imaging modalities such as echocardiography, cardiac MRI, and CT were critically evaluated for their role in procedural planning and execution.

Main Results:

  • TPVR is increasingly adopted, demonstrating favorable outcomes including RV remodeling, reduction in PR/PS, functional improvement, and shorter hospital stays compared to surgery.
  • Various devices (Melody, SAPIEN, Harmony, Venus P-valve) are utilized based on right ventricular outflow tract (RVOT) anatomy and dimensions.
  • Critical factors for success include meticulous pre-procedural imaging and multidisciplinary team assessment for safe deployment and optimal valve positioning.

Conclusions:

  • TPVR represents a safe and effective therapeutic option for carefully selected patients with PR or PS post-congenital heart repair.
  • A standardized, imaging-guided approach with robust multidisciplinary oversight is paramount for successful TPVR.
  • Further research is warranted to evaluate long-term valve durability and to refine TPVR strategies for pediatric and high-risk patient populations.